Sniffing out the next ASX biotech takeover target
With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be next.
With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be next.
The annual resources calendar turns to Canada this weekend for one of the world’s biggest and most influential mining conferences.
American Salars Lithium is acquiring the Leduc East project in Quebec that has 35 known pegmatites and historical feldspar and mica production.
CSE-listed battery metals explorer American Salars Lithium has spread its wings with the acquisition of the LCT pegmatite rich Jaguaribe project in northern Brazil.
Following key online promotional events, EZZ Life Sciences reports surging Chinese sales of its health and beauty products.
Lithium-producing giant SQM is set to fund exploration to earn up to 70% of iTech’s Reynolds Range lithium project in the NT.
Antipa’s latest drilling highlights brown and greenfields growth potential at Minyari Dome project.
Race Oncology’s CEO Dr Daniel Tillett joins Fraser Palamara on Stockhead TV to talk about it’s recent collaboration with Monash University.
Australia’s love of betting is as strong as ever, although the wagering market is consolidating. One asset manager is tipping BlueBet and PointsBet to succeed.
Singular Health Group has inked a major deal with the Miami-based Provider Network Solutions for its 3Dicom software.
Weebit Nano CEO Coby Hanoch gives Stockhead TV the skinny on a semiconductor industry with almost-unquantifiable influence.
Supermajor Shell’s reportedly successful appraisal program at the Taroom Trough could pry the play open to ease east coast gas woes.
Octava Minerals is kicking off a drill campaign at its Yallalong antimony project northeast of Geraldton.
Western Australia’s remote Paterson Province is looking interesting once again, particularly for junior explorer Antipa Minerals. Kristie Batten reports.
Original URL: https://www.heraldsun.com.au/business/stockhead/page/198